Navigation Links
Partner Kristine Kraft Appointed to the Plaintiffs’ Steering Committee (PSC) in Federal Testosterone Replacement Therapy MDL, Schlichter, Bogard & Denton, LLP Reports

St. Louis, MO (PRWEB) August 13, 2014

A federal judge recently appointed Kristine Kraft, a partner at Schlichter, Bogard & Denton, LLP, to the Plaintiffs’ Steering Committee (PSC) in the Multidistrict Litigation (MDL) involving the manufacturers of low testosterone replacement therapies (Case Management Order No. 4, In Re: Testosterone Therapy Products Liability Litigation, Case No. 1:14-cv-1748, MDL No. 2545, N.D. Ill.). The Honorable Matthew F. Kennelly of the U.S. District Court for the Northern District of Illinois appointed Kraft to the PSC in July 2014. Kraft and other appointed co-counsel will be leaders in the national litigation involving victims who allege to have been seriously injured while using testosterone replacement therapies.

“We continue to hear from individuals who allege to have experienced life-threatening and serious injuries after using testosterone products,” says Kraft. “I am honored to have been appointed as a leader in this litigation and eager to fight for the rights of victims who allege suffering injuries after using these drugs.” The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have been injured after using testosterone products.

On January 31, 2014, the United States Food and Drug Administration (FDA) issued a Safety Announcement that it is investigating a potential link between testosterone use and stroke, myocardial infarction (MI), and death, as demonstrated by published studies. The first study that prompted the FDA’s Safety Announcement was published in the Journal of the American Medical Association (JAMA) in November 2013 and suggested that testosterone replacement drugs may increase the risk of heart attack, stroke and death. The second study, published in the online journal PLos ONE on January 29, 2014, concluded that older men, and younger men with pre-existing diagnosed heart disease, have an increased risk of heart attack following initiation of testosterone therapy.

About Schlichter, Bogard & Denton, LLP
Schlichter, Bogard & Denton, LLP is a unique law firm that has held numerous leadership positions in national litigations involving dangerous pharmaceutical medications, unsafe medical devices and toxic torts, including but not limited to: In re: Testosterone Replacement Therapy Products Liability Litigation (MDL 2545, Case No. 14-md-2545, N.D. Ill.), In re: Pradaxa® (Dabigatran Etexilate) Products Liability (MDL 2385, Case No. 12-md-2385, S.D. Ill.), In re: E.I. Du Pont de Nemours and Company C-8 Personal Injury Litigation (MDL 2433, Case No. 13-md-2433, S.D. Ohio), In re: Yasmin® and Yaz® (Drospirenone) Marketing and Sales Practices and Products Liability Litigation (MDL 2100, Case No. 09-md-2100, S.D. Ill.), In re: NuvaRing® Products Liability Litigation (MDL 1964, Case No. 08-md-1964, E.D. Mo.), In re: Gadolinium-Based Contrast Products Liability Litigation (MDL 1909, Case No. 08-md-50000, N.D. Ohio), and In re: Ortho Evra® Products Liability Litigation (MDL 1742, Case No. 06-md-40000, N.D. Ohio).

The Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton aggressively represent clients who allege to have suffered injuries as a result of dangerous pharmaceutical medications and unsafe medical devices. The attorneys at Schlichter, Bogard & Denton, LLP who represent such victims include Roger Denton, Kristine Kraft, Beth Wilkins Flieger, Ashley Brittain Landers, and Tara Rocque. With hard work, creative thinking, and strong trial skills, we have earned an outstanding nationwide reputation by representing thousands of individuals who have suffered serious and life-threatening injuries, or even death.

If you or a loved one have suffered serious injuries after using testosterone therapy drugs, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.

Schlichter, Bogard & Denton, LLP also welcomes the opportunity to work with other attorneys on these types of cases. We are available to either handle these cases or work as co-counsel, so other attorneys with these types of cases are invited to contact an attorney at the firm to explore this opportunity.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Women With Older Partners More Often Admitted to Nursing Homes
2. University of Houston Graduate College of Social Work announces partnership with MD Anderson
3. Partnership provides inclusive workout
4. Global Cassava Partnership for the 21st Century (GCP21)
5. FDA clears test developed in partnership with VCU researcher
6. Cyber exercise partners help you go the distance
7. ACP-New York State Chapter partnership results in patient safety organization recognition
8. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
9. Partners with SwaddleDesigns
10. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
11. The Biochar Company Partners with Hawaii Biochar Products
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at ... Michigan, have come together on Thanksgiving Day to share the things that they ... on the Serenity Point YouTube channel, patients displayed what they wrote on index ...
(Date:11/26/2015)... NE (PRWEB) , ... November 26, 2015 , ... Jobs ... searched by healthcare professionals and offered by healthcare staffing agency Aureus Medical Group ... during the month of October 2015 among those searching for healthcare jobs through the ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
(Date:11/25/2015)... Omaha, Neb. (PRWEB) , ... November 25, 2015 ... ... nurse staffing companies, has been recognized once again for its stellar workplace culture ... Places to Work.” , Medical Solutions’ Cincinnati office was named a ...
(Date:11/25/2015)... ... 25, 2015 , ... For the first time, Vitalalert is donating half of ... campaign. The partnership between the two groups began in 2014 with Vitalalert pledging a ... MAP International was founded in 1954 and is an international Christian-based health organization whose ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... , Nov. 25, 2015  ARKRAY USA ... continues to provide evidence demonstrating the accuracy of its ... Congress on Insulin Resistance, Diabetes and Cardiovascular Disease in ... both the Company,s GLUCOCARD ® 01 meter and ... accuracy requirements. The ability to accurately measure glucose levels ...
Breaking Medicine Technology: